| Hentz, Marc W. (AMP Biosimilars AG 201505 CEO before AMP-Therapeutics GmbH 201210 Managing Director) |
Chief Executive Officer (CEO) |
AMP Biosimilars AG |
Germany |
| Hentze, Matthias (EMBL 201702 Director) |
n. a. |
EMBL (European Molecular Biology Laboratory) |
Germany |
| Henze, Kirstin (Danaher 201104 Director Communications + Corporate Identity at Leica Microsystems) |
Public Relations Manager / Investor Relations Manager |
Danaher (Group) |
Germany |
| Hepberger, Rainer (Innovacell 201204– CFO) |
Chief Financial Officer (CFO) |
Innovacell Biotechnologie AG |
Austria |
| Herbeaux, Jean-Luc (Evonik 201112 Head of Health Care business) |
President/Director/Head Business Group/Unit/Division |
Evonik (Group) |
Germany |
| Herberg, Axel (Gerresheimer 200703 President + CEO) |
Chief Executive Officer (CEO) |
Gerresheimer (Group) |
Germany |
| Herbers, Karin (SunGene GmbH 200502 Managing Director) |
Managing Director |
BASF (Group) |
Germany |
| Herbert, Susan Jane (Merck (DE) 201109 Head Global Portfolio Development at Merck Serono) |
Business Development Manager / Strategy Manager |
Merck (DE) (Group) |
Germany |
| Herklots, Hans (LifeSci 201805 LifeSci Advisors before Carpicorn One + TiGenix) |
Public Relations Manager / Investor Relations Manager |
LifeSci (Group) |
United States (USA) |
| Herman, Gerald N. (Bruker Corp 201806– CFO before Interim CFO joined 12/16 as VP + Corp Controller before Parexel) |
Chief Financial Officer (CFO) |
Bruker Corporation (Group) |
United States (USA) |
| Hermance, Frank S. (Ametek 201408 CEO) |
Chief Executive Officer (CEO) |
AMETEK (Group) |
United States (USA) |
| Hermann, Frank (4SC 201610– promoted CDO joined recently from BMS) |
Research & Development Manager |
4SC (Group) |
Germany |
| Hermann, Ralf (Eppendorf –201610 Chief Marketing + Portfolio Manager LEFT 10/16 before Sartorius/Vivascience + Qiagen) |
Board member, executive |
Eppendorf (Group) |
Germany |
| Hermansen, Ronny (Axis-Shield 200704– Finance Director before merger Axis Biochemicals Finance Director) |
Chief Financial Officer (CFO) |
Alere (Group) |
United Kingdom (GB) |
| Hermes, Rene (Definiens AG 200611 Vice Pres Marketing) |
n. a. |
AstraZeneca (Group) |
Germany |
| Hernday, Natasha (Seattle Genetics 201306 VP Corporate Development) |
Business Development Manager / Strategy Manager |
Seattle Genetics Inc. (Nasdaq: SGEN) |
United States (USA) |
| Herndon, Russell (Hydra Biosciences 201404 CEO) |
Chief Executive Officer (CEO) |
Hydra Biosciences Inc. |
United States (USA) |
| Herr, Stefan (EMBL Ventures) |
Partner (venture partner) |
EMBL (European Molecular Biology Laboratory) |
Germany |
| Herrema, Greg (Thermo Fisher 200703 President Scientific Instruments) |
n. a. |
Thermo Fisher (Group) |
United States (USA) |
| Herrendorff, Ruben (Polyneuron 201805 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Polyneuron Pharmaceuticals AG |
Switzerland |
| Herrenknecht, Kurt (SciArcum 201110– before Proteros + Zukunftsfonds Heilbronn + PerkinElmer + Evotec + Eisai) |
Business Development Manager / Strategy Manager |
SciArcum Biotech Consulting – Dr. Kurt Herrenknecht |
Germany |
| Herrmann, Alexander (Gilupi GmbH 201605– Managing Director before Capsulution + Metabolomic Discoveries) |
General Manager (management) |
Viroad (Group) |
Germany |
| Herrmann, Andreas (Valerius Biopharma 201805 CEO + Founder before Alvotech + Celonic + Baliopharm + Synimmune + Cardion) |
Chief Executive Officer (CEO) |
Valerius Biopharma AG |
Switzerland |
| Herrmann, Brigitte (Rheinland-Pfalz (govt) 201601 Head of Venture Capital at ISB) |
Investment Manager |
Investitions- und Strukturbank Rheinland-Pfalz (ISB) |
Germany |
| Herrmann, Ira (Life & Brain GmbH 201611 Head of Administration + Business Development) |
Business Development Manager / Strategy Manager |
Life & Brain GmbH |
Germany |
| Herrmann, Max (Silence Therapeutics 201108 CFO + acting CEO beforre Intercytex 200809– CFO) |
Chief Financial Officer (CFO) |
Silence Therapeutics (Group) |
United Kingdom (GB) |
| Herrmann, Reinhard (AVISO GmbH 200711 Managing Director) |
Managing Director |
AVISO GmbH Mechatronic Systems |
Germany |
| Herrmann, Rüdiger (Mayer Brown 200809 Frankfurt/M) |
n. a. |
Mayer Brown LLP |
Germany |
| Herron, Jennifer (MorphoSys 201807– President MorphoSys US Inc + EVP Global Commercial before Ariad + BMS) |
President/Director/Head Business Group/Unit/Division |
Bio-Rad (Group) |
United States (USA) |
| Hertig, Christina (Galenica 201112 Head Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Galenica (Group) |
Switzerland |
| Hertzberg, Suzan (Ipsogen 200810 President of Ipsogen Inc + VP Corporate BusDev) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
United States (USA) |
| Herzog, Ruth |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Hess, Heribert (Tecan 2012– Manager Commercial Operations D-A-CH) |
Sales Manager / Marketing Manager |
Tecan (Group) |
Germany |
| Hess, Matthias (AnalytiCon Discovery 200504) |
n. a. |
BRAIN (Group) |
Germany |
| Hessing, Michael |
n. a. |
Dr. Schmidt (Group) |
Germany |
| Hesslein, Robert (Bob) (Voyager Therapeutics 201901– General Counsel before Foundation Medicine + Genzyme) |
General Counsel / Chief Legal Officer (CLO) |
Voyager Therapeutics Inc. (Nasdaq: VYGR) |
United States (USA) |
| Hetke, Christian (Futalis GmbH 201111– Managing Director + Co-founder) |
Managing Director |
Futalis GmbH |
Germany |
| Hettich, Christof (Kanzlei Rittershaus + Dievini Hopp) |
Attorney / Lawyer |
Rittershaus Rechtsanwälte Partnerschaftsgesellschaft mbH |
Germany |
| Heuer, Michael (Roche 201810– interim CEO of Roche Diagnostics before Region Head EMEA + Latin America joined BM 1983) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
| Heukamp, Wessel (Freshfields Bruckhaus Deringer 201610) |
Attorney / Lawyer |
Freshfields (Group) |
United Kingdom (GB) |
| Heumann, Hermann (Silantes GmbH 201902 Managing Director) |
Managing Director |
Silantes GmbH |
|
| Heumann, Klaus (Biomax 200611 CEO) |
Chief Executive Officer (CEO) |
Biomax (Group) |
Germany |
| Heumann, Klaus (Univ Mainz 200701 Professor for Inorganic and Analytical Chemistry) |
Professor |
University of Mainz (Johannes Gutenberg University) |
Germany |
| Heydler, Thomas P. (Definiens 200411– CEO) |
Chief Executive Officer (CEO) |
AstraZeneca (Group) |
Germany |
| Heyne, Wilfried (Humedics GmbH 201110 Managing Director) |
Managing Director |
Humedics GmbH |
Germany |
| Heyse, Stephan (Genedata 200701 Head of Genedata Screener) |
Product Manager (personnel) |
Genedata (Group) |
Switzerland |
| Heß, Markus (Astra Diagnostics 201105 Managing Director) |
Managing Director |
ADT Altona Diagnostic Technologies GmbH (Altona Diagnostics) |
Germany |
| Heß, Rüdiger (PXBioVision 201104 Managing Director) |
Managing Director |
PXBioVisioN GmbH |
Germany |
| Heßler, Nadine (JeNaCell GmbH 201210 Managing Director) |
Managing Director |
JeNaCell GmbH |
Germany |
| Hickey, Dave (Siemens 200805 SVP Strategic Planning + BusDev at Siemens Healthcare Diagnostics) |
Business Development Manager / Strategy Manager |
Siemens (Group) |
Germany |
| Hicks, Dave (Danaher 201004 VP + General Manager Pharmaceuticals + Proteomics at AB SCIEX) |
General Manager (management) |
Danaher (Group) |
Canada |
| Higashi, Shunichi (Miraca 201808 CEO of Srl Inc) |
Chief Executive Officer (CEO) |
Miraca (Group) |
Japan |
| Higgins, Arthur J. (Bayer HealthCare CEO 200407–201004 LEFT 4/10) |
Chief Executive Officer (CEO) |
Bayer (Group) |
Germany |
| Higgins, John L. (Ligand –200710– President + CEO) |
Chief Executive Officer (CEO) |
Ligand (Group) |
United States (USA) |
| Higham, Paul G. (Glycotope 201601– CEO before Immatics 200808–201508 CEO before Ark Therapeutics + GlaxoWellcome) |
Chief Executive Officer (CEO) |
Glycotope (Group) |
Germany |
| Hilbert, Helmut (Curetis 201303– Head Business Development before Qiagen Business Development) |
Business Development Manager / Strategy Manager |
Curetis (Group) |
Germany |
| Hildemann, Steven (Merck (DE) 201401– Global CMO at Merck Serono before MSD/Merck US) |
Chief Medical Officer (CMO) |
Merck (DE) (Group) |
Germany |
| Hildinger, Markus (ExcellGene 200905 CBO) |
Chief Business Officer (CBO) |
ExcellGene S.A. |
Switzerland |
| Hilfrich, Ralf (Abviris 2014– Managing Director + Co-Founder) |
Managing Director |
Abviris Deutschland GmbH |
Germany |
| Hilkert, Andreas (Thermo Fisher 201512 Senior Manager Product Marketing Inorganic Mass Spectrometry) |
Product Manager (personnel) |
Thermo Fisher (Group) |
United States (USA) |
| Hill, Adam M. (Oncimmune 201810– CEO joined 201803 before McLaren Applied Technologies) |
Chief Executive Officer (CEO) |
Oncimmune (Group) |
United Kingdom (GB) |
| Hill, Adrian (Univ Oxford 201506 Professor + Director of Jenner Institute) |
Professor |
University of Oxford |
United Kingdom (GB) |
| Hillebrand, Timo (Analytik Jena 201101 Managing Director AJ Innusreen GmbH) |
Managing Director |
Endress+Hauser (Group) |
Germany |
| Hillenkamp, Franz (Univ Münster Prof, co-inventor MALDI-TOF MS) |
Professor |
University of Münster (Westfälische Wilhelms-Universität Münster) |
Germany |
| Hillgrove, Allan (Boehringer 201301– promoted Managing Director Div Marketing + Sales Prescription Medicines) |
Managing Director |
Boehringer Ingelheim (Group) |
Germany |
| Hillisch, Alexander (Bayer HealthCare AG 200508) |
n. a. |
Bayer (Group) |
Germany |
| Hils, Martin (Zedira 201106 CEO + co-founder before N-Zyme Biotec) |
Managing Director |
Zedira GmbH |
Germany |
| Hilterhaus, Dierk (Xtal Concepts 201208 Managing Director) |
Managing Director |
Xtal Concepts GmbH |
Germany |
| Hilvert, Donald (ETH Zürich 201310 Professor at Lab for Organic Chemistry) |
Professor |
ETH Zürich (ETHZ) |
Switzerland |
| Himmler, Gottfried (f-star 200709 CEO + co-founder) |
Chief Executive Officer (CEO) |
F-Star (Group) |
Austria |
| Hing, Paul (Sensovation 201110 CTO) |
Chief Technology/Technical Officer (CTO) |
Miltenyi Biotec (Group) |
Germany |
| Hingst, Thomas (Logic Works 2001– Managing Director + Co-founder) |
Managing Director |
Logic Works GmbH |
Germany |
| Hinterding, Klaus (Proteros 201202– CSO before Roche + Novartis) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Proteros (Group) |
Germany |
| Hintsche, Rainer (2000– eBiochip Systems founder + Managing Director) |
Managing Director |
Endress+Hauser (Group) |
Germany |
| Hinzen, Berthold (Bayer 201003 Head Global BusDev + Licensing General Medicine) |
Business Development Manager / Strategy Manager |
Bayer (Group) |
Germany |
| Hinzen, Dieter (BI 200409) |
n. a. |
Boehringer Ingelheim (Group) |
Germany |
| Hippe, Alan (Roche 201104– CFO before ThyssenKrupp + Continental + Fraport) |
Chief Financial Officer (CFO) |
Roche (Group) |
Switzerland |
| Hippolyte, Christopher (Ruth Group 201612) |
Public Relations Manager / Investor Relations Manager |
Ruth Group, The (TRG) |
United States (USA) |
| Hirano, Hiro (KKR 201506 Head KKR Japan) |
President/Director/Head Business Group/Unit/Division |
Kohlberg Kravis Roberts (KKR) (Group) |
United States (USA) |
| Hirashima, Shoji (Daiichi Sankyo 201302 Managing Director of U3 Pharma GmbH) |
Managing Director |
Daiichi Sankyo (Group) |
Germany |
| Hirawat, Samit (Novartis 201710 EVP + Head Global Drug Development at Novartis Oncology) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Switzerland |
| Hirsbrunner, Fritz (Galenica –201112 CFO + Deputy CEO ) |
Chief Financial Officer (CFO) |
Galenica (Group) |
Switzerland |
| Hirsch, Hendrik (CMS 201408 Partner at CMS Hasche Sigle Ffm) |
Attorney / Lawyer |
CMS (Group) |
Germany |
| Hirse, Thomas (CMS Hasche Sigle 2007 Attorney at CMS Hasche Sigle Düsseldorf before Linklaters LLP Köln) |
Attorney / Lawyer |
CMS (Group) |
Germany |
| Hirst, Simon (Sygnature Discovery 201112 CEO + Founder) |
Chief Executive Officer (CEO) |
Sygnature Discovery Ltd. |
United Kingdom (GB) |
| Hiruta, Kazuyuki (20170823 CEO of Icon Genetics GmbH) |
Managing Director |
Denka (Group) |
Germany |
| Hjortsmark, Maria (Gyros 201307 Global Marketing Director before Halo Genomics CBO) |
Sales Manager / Marketing Manager |
Gyros (Group) |
Sweden |
| Ho, Tony (CRISPR Therapeutics 201708– EVP + Head RnD) |
n. a. |
CRISPR Therapeutics (Group) |
Switzerland |
| Hobbs, Eric (Berkeley Lights 201709 CEO) |
Chief Executive Officer (CEO) |
Berkeley Lights Inc. (BLI) |
United States (USA) |
| Hobe, Herr (Intavis 200809) |
Sales Manager / Marketing Manager |
HB Technologies (Group) |
Germany |
| Hoch, Thomas (EVP Capital 201106 Executive Board Director) |
Board member, executive |
EVP Capital Management AG |
Germany |
| Hochmair, Erwin (MED-EL Co-Founder) |
Company Founder |
MED-EL Elektromedizinische Geräte GmbH |
Austria |
| Hochmair, Ingeborg (MED-EL 201611 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
MED-EL Elektromedizinische Geräte GmbH |
Austria |
| Hochstrasser, Denis (University Geneva 201005 Professor HUG Head Dept Genetic and Laboratory Medicine) |
Professor |
University of Geneva (Université de Genève, UNIGE) |
Switzerland |
| Hochwimmer, Georg (SmartDyeLivery GmbH 20602 Managing Director) |
Managing Director |
SmartDyeLivery GmbH |
Germany |
| Hock, Björn (Merck (DE) 201507 Global Head Protein Engineering + Antibody Technologies at Merck Sereno) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
| Hock, Christoph (Neurimmune 201808– CMO before Co-Founder + Board Member main org Univ Zurich) |
Chief Medical Officer (CMO) |
Neurimmune AG |
Switzerland |
| Hodits, Regina (Wellington Partners 201101– General Partner before part-time advisor before Atlas Venture until 201001) |
General Partner (venture partner) |
Wellington Partners Venture Capital GmbH |
Germany |
| Hoem, Jon H. (Miracor 200806– CEO) |
Chief Executive Officer (CEO) |
Miracor (Group) |
Austria |
| Hoenlinger, Sheida (SGS 201610 Director Life Sciences Germany) |
President/Director/Head Business Group/Unit/Division |
SGS (Group) |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 23 24 25 ... 65 66 67 
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lsus-life-sciences-usa-com-beta.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
